SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-042212
Filing Date
2022-11-18
Accepted
2022-11-18 08:02:42
Documents
4
Period of Report
2022-12-16

Document Format Files

Seq Description Document Type Size
1 PRE14A ny20005930x1_pre14a.htm PRE 14A 489891
2 logo_statera.jpg GRAPHIC 59986
3 ny20005930x1_pc01.jpg GRAPHIC 630049
4 ny20005930x1_pc02.jpg GRAPHIC 513022
  Complete submission text file 0001140361-22-042212.txt   2147190
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32954 | Film No.: 221400581
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences